Frontiers in Neurology | Multiple Sclerosis and Neuroimmunology

Systematic Review

Published on 06 Dec 2024

Comparative efficacy and tolerability of ublituximab vs. other monoclonal antibodies in the treatment of relapsing multiple sclerosis: a systematic review and network meta-analysis of randomized trials

in Multiple Sclerosis and Neuroimmunology

Eoin Moloney
Atefeh Mashayekhi
Sakshi Sharma
Vasileios Kontogiannis
Amir Ansaripour
Wallace Brownlee
David Paling
Mehdi Javanbakht

Frontiers in Neurology

doi 10.3389/fneur.2024.1479476

2,729 views

Original Research

Published on 04 Dec 2024

Integrative multi-omics approach using random forest and artificial neural network models for early diagnosis and immune infiltration characterization in ischemic stroke

in Multiple Sclerosis and Neuroimmunology

Ling Lin
Chunmao Guo
Hanna Jin
Haixiong Huang
Fan Luo
Ying Wang
Dongqi Li
Yuanxin Zhang
Yuqian Xu
Chanyan Zhu

Frontiers in Neurology

doi 10.3389/fneur.2024.1475582

2,150 views
1 citation

Original Research

Published on 27 Nov 2024

Combining gene expression microarrays and Mendelian randomization: exploring key immune-related genes in multiple sclerosis

in Multiple Sclerosis and Neuroimmunology

Shuangfeng Ding
Yunyun Zhang
Yunzhe Tang
Ying Zhang
Mingyuan Liu

Frontiers in Neurology

doi 10.3389/fneur.2024.1437778

2,064 views
1 citation

Systematic Review

Published on 26 Nov 2024

Comparison of different exercise modalities on fatigue and muscular fitness in patients with multiple sclerosis: a systematic review with network, and dose–response meta-analyses

in Multiple Sclerosis and Neuroimmunology

Xi-Nuan Zhang
Zhi-De Liang
Ming-Da Li

Frontiers in Neurology

doi 10.3389/fneur.2024.1494368

2,427 views

Review

Published on 20 Nov 2024

Unveiling the fate and potential neuroprotective role of neural stem/progenitor cells in multiple sclerosis

in Multiple Sclerosis and Neuroimmunology

Nora Hijal
Malak Fouani
Bassel Awada

Frontiers in Neurology

doi 10.3389/fneur.2024.1438404

1,543 views
1 citation

Original Research

Published on 19 Nov 2024

Efgartigimod treatment in patients with anti-MuSK-positive myasthenia gravis in exacerbation

in Multiple Sclerosis and Neuroimmunology

Fangyi Shi
Jiaxin Chen
Li Feng
Rong Lai
Hongyan Zhou
Xunsha Sun
Cunzhou Shen
Jiezhen Feng
Huiyu Feng
Haiyan Wang

Frontiers in Neurology

doi 10.3389/fneur.2024.1486659

2,152 views
1 citation

Original Research

Published on 15 Nov 2024

Smartphone tests quantify lower extremities dysfunction in multiple sclerosis

in Multiple Sclerosis and Neuroimmunology

Kimberly Jin
Peter Kosa
Bibiana Bielekova

Frontiers in Neurology

doi 10.3389/fneur.2024.1408224

2,160 views

Original Research

Published on 12 Nov 2024

Causal relationship between immune cells and Guillain-Barré syndrome: a Mendelian randomization study

in Multiple Sclerosis and Neuroimmunology

Huaiquan Liu
Shuoshuo Shao
Bo Chen
Shili Yang
Xinyan Zhang

Frontiers in Neurology

doi 10.3389/fneur.2024.1446472

1,929 views

Original Research

Published on 06 Nov 2024

A comparison of natalizumab’s effects on SDMT between pediatric-onset and adult-onset multiple sclerosis patients

in Multiple Sclerosis and Neuroimmunology

Marco Puthenparampil
Graziana Scialpi
Marta Gaggiola
Giovanni Zanotelli
Alessandro Miscioscia
Angela Berardi
Alice Riccardi
Margherita Nosadini
Stefano Sartori
Paola Perini

Frontiers in Neurology

doi 10.3389/fneur.2024.1475161

993 views

Case Report

Published on 30 Oct 2024

Case report: Primary cytomegalovirus infection in a patient with late onset multiple sclerosis treated with dimethyl fumarate

in Multiple Sclerosis and Neuroimmunology

Julia Sabin Muñoz
Alberto Díaz-De Santiago
José Cebrián Escudero
J. A. García Merino

Frontiers in Neurology

doi 10.3389/fneur.2024.1363876

1,328 views
2 citations

Brief Research Report

Published on 30 Oct 2024

Clinical trajectories of patients with multiple sclerosis from onset and their relationship with serum neurofilament light chain levels

in Multiple Sclerosis and Neuroimmunology

Carlos Quintanilla-Bordás
Laura Cubas-Núñez
Jéssica Castillo-Villalba
Sara Carratalá-Boscá
Raquel Gasque-Rubio
Jordi Tortosa-Carreres
Carmen Alcalá
Lorena Forés-Toribio
Celia Lucas
David Gorriz

Frontiers in Neurology

doi 10.3389/fneur.2024.1477335

1,219 views
1 citation

Original Research

Published on 30 Oct 2024

Clinical characteristics and prognosis analysis of acute symptomatic seizures secondary to autoimmune encephalitis

in Multiple Sclerosis and Neuroimmunology

Mengyun Li
Qing Zhang
Xu Wang
Bofei Tan
Qiang Liu

Frontiers in Neurology

doi 10.3389/fneur.2024.1474888

1,510 views
2 citations

Original Research

Published on 24 Oct 2024

Improvements in no evidence of disease activity with ublituximab vs. teriflunomide in the ULTIMATE phase 3 studies in relapsing multiple sclerosis

in Multiple Sclerosis and Neuroimmunology

Enrique Alvarez
Lawrence Steinman
Edward J. Fox
Hans-Peter Hartung
Peiqing Qian
Sibyl Wray
Derrick Robertson
Krzysztof Selmaj
Daniel Wynn
Koby Mok

Frontiers in Neurology

doi 10.3389/fneur.2024.1473284

2,602 views

Review

Published on 22 Oct 2024

The benefits of photobiomodulation in animal models of multiple sclerosis: a systematic review and meta-analysis

in Multiple Sclerosis and Neuroimmunology

Zubair Ahmed

Frontiers in Neurology

doi 10.3389/fneur.2024.1482096

1,576 views

Original Research

Published on 10 Oct 2024

Analysis and visualization of the effect of multiple sclerosis on biological brain age

in Multiple Sclerosis and Neuroimmunology

Catharina J. A. Romme
Emma A. M. Stanley
Pauline Mouches
Matthias Wilms
G. Bruce Pike
Luanne M. Metz
Nils D. Forkert

Frontiers in Neurology

doi 10.3389/fneur.2024.1423485

1,500 views

Systematic Review

Published on 02 Oct 2024

Global prevalence of fatigue in patients with multiple sclerosis: a systematic review and meta-analysis

in Multiple Sclerosis and Neuroimmunology

Xiaodong Yi
Yue Zhang
Qiufeng Du
Jing Kang
Shuang Song
Tao Li
Yunlan Jiang

Frontiers in Neurology

doi 10.3389/fneur.2024.1457788

2,496 views
2 citations